Cigarette smoking and fatty liver

Annals of Hepatology

Volumn 9, Issue 2, 2010, Pages 215-218

  Ponciano Rodríguez, Guadalupe ^a   Méndez Sánchez, Nahum ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FATTY LIVER; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN SENSITIVITY; LETTER; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; PUBLIC HEALTH PROBLEM; RISK FACTOR; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 79956061105     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31668-0     Document Type: Letter

References (30)

1. Azzalini L, Ferrer E, Ramalho LN, Moreno M, Domfnguez M, Colmenero J, Peinado VI, et al. Cigarette Smoking Exacerbates Nonalcoholic Fatty Liver Disease in Obese Rats. Hepatology 2010; 51(5): 1567-1576.
2. Ponciano-Rodriguez G. Tratamiento integral del tabaquismo. Mexico: Ed. Trillas; 2007.
3. Consejo Nacional Contra las Adicciones- CONADIC. Mexico: Encuesta Nacional de Adicciones; 2008.
4. Valdes-Salgado R, Reynales-Shigematsu LM, Lazcano-Ponce EC, Hernandez-Avila M. Susceptibility to smoking among adolescents and its implications for Mexico's tobacco control programs. Analysis of the Global Youth Tobacco Survey 2003-2004 and 2006-2007. Int J Environ Res Public Health 2009; 6: 1254-1267.
5. Kuri-Morales PA, Gonzalez-Roldan JF, Hoy MJ, Cortes-Ramirez M. Epidemiologic del tabaquismo en Mexico. Salud Publica Mex 2006; 48(Supl. 1): S91-S98.
6. Waters H, Saenz de Miera B, Ross H, Reynales-Shigematsu LM. The economics and tobacco taxation en Mexico. Paris: International Union Against Tuberculosis and Lung Disease; 2010.
7. Fernald CL, Guttierrez JP, Neufeld ML, Olaiz G, Bertozzi MF, Mietus-Snyder M, Gertler JP. High incidence of obesity among the poor in Mexico. JAMA 2004; 291(21): 2544-2545.
8. Vazquez-Martinez JL, Gomez-Dantes H, Gomez-Garcia F, Lara-Rodriguez MA, Navarrete EJ, Perez-Perez G. Obesu-ty and overweight in IMSS female workers in Mexico City. Salud Publica Mexico 2005; 47: 268-275.
9. Nota de internet
10. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe EM. Current concepts in the pathogenesis of Nonalcoholic fatty liver disease. Liver International 2007; 27(4): 423-433.
11. Mendez-Sanchez N, Chavez-Tapia NC, Uribe EM. Higado graso no alcoholic. Rev Invest Clin 2004; 56(1): 72-82.
12. Mendez-Sanchez N, Chavez-Tapia NC, Uribe EM. Obesidad y esteatohepatitis no alcoholica. Gac Med Mex 2004; 140(Supl. 2): S67-S72.
13. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science 2008; 11: 141-450.
14. Gordon R, Kannel WE, Dawber TR, McGee D. Changes associated with quitting cigarette smoking The Framingham Study. Am Ht J 1975; 90: 322-328.
15. Ponciano-Rodriguez G, Morales RA. Evaluacion del Progra-ma de tratamiento para le cesacion del tabaquismo en la clinica de la Facultad de Medicina de la UNAM. Salud Publico Mex 2007; 49(Supl. 2): S247- S256.
16. Chatkin R, Chatkin JM. Smoking in body weight: can phy-siopatology and genetics explain this association? J Brasil Pneumol 2007; 33(6): 712-719.
17. Cousino KL, Corwin JE, Ceballos MR. Leptin, hunger, and body weight: influence of gender, tobacco smoking and smoking abstinence. Addictive Behaviors 2004; 29: 921-927.
18. Mendez-Sanchez N, Ponciano-Rodriguez G, Chavez-Tapia NC, Uribe EM. El papel de la leptina en el desarrollo de es-teatosis hepatica y litiasis biliar. Gac Med Mex 2005; 141(6): 495-499.
19. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. AmJ Clin Nutr 2008; 87: 801-809.
20. Komiya H, Mori Y, Yokose T, Tajima N. Smoking as a risk factor for visceral fat accumulation in Japanese men. To-hoku J Exp Med 2006; 208: 123-132.
21. Pisinger C, Jorgensen T. Waist circumference and weight following smoking cessation in a general population: The Inter99 study. Prev Med 2007; 44: 290-5.
22. Koster A, Leitzmann MF, Schatzkin A, Adams FK, van Eijk JTM, Hollenbeck AR, Harris BT. The combined relations of adiposity and smoking on mortality. Am J Clin Nutr 2008; 88: 1206-1212.
23. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218-224.
24. Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 2009; 51(3): 535-547.
25. Yuan H, Shyy JYJ, Martin-Green M. Second hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 2009; 51: 535-547.
26. Moon J-O, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia inducible factor-1 alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G582-G592.
27. Zein CO. Clearing the smoke in chronic liver diseases. He-patoloSy 2010; 51(5): 1487-1489.
28. Haenle MM, Brockmann SO, Kron M, Bertling U, Mason RA, Steinbach G, et al. Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health 2006; 6: 233-244.
29. Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 2006; 12: 5196-5200.
30. Suzuki A, Lindor K, Saver J, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005; 43: 1060-1066.